Burkitt lymphoma part 1 of 3 the selection, dosing, and administration of anticancer agents and the management of associated toxicities are complex. Line therapy in treating patients with stage iiib or stage iv non. A phase ii study of dasatinib and dexamethasone as primary. Patients may have received one and only one cycle of chemotherapy prior to enrolling on cancer and leukemia group b calgb 30610, which must have included carboplatin or cisplatin and etoposide. Smallcell lung cancer sclc represents 10% to 15% of lung cancer cases and. Calgb 30610, phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin or carboplatin and etoposide protocol version date092717 v. Prophylactic cranial irradiation for patients with smallcell lung cancer in complete remission. Calgb 30610 pdf phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide. Goals of 10403 study to estimate feasibility and dfs using a successful cog regimen in adult cooperative group setting in usa flow sheets to evaluate compliance with dosesschedule of chemotherapy to obtain insights into agespecific molecular pathogenesis and to identify prognostic markers. As a service to our customers we are providing this early version of the manuscript. Calgb 30610 phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin or carboplatin and etoposide a151216 adjuvant lung cancer enrichment marker identification and sequencing trial alchemist a081105 randomized double blind placebo controlled study of. Calgb failed to meet its primary endpoint of os cetuximab is not superior to avastin in 1l kraswt. Calgb 30610 rtog 0538 limited small cell 45 gy bid 3 weeks 61. We encourage the study authors to analyse quality of life data for patients as well as caregiver burden, and other research groups to conduct a formal economic analysis.
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia. However, patient accrual to the 45 gy and 70 gy arms is. Interim toxicity analysis for patients with limited. Radiation therapy regimens in treating patients with limited. This situation might change if the ongoing phase 3 trial calgb 30610 nct00632853, comparing 45 gy twicedaily with 70 gy oncedaily in the usa, reaches different conclusions. Impact of induction chemotherapy on estimated risk of. This is a pdf file of an unedited manuscript that has been accepted for publication. A phase ii study of dasatinib and dexamethasone as primary therapy followed by hematopoietic cell. No prior radiotherapy or chemotherapy except for the chemotherapy described in the bullet above for sclc.
Christakis, for the cancer and leukemia group b, measuring diseasefree survival and cancer relapse using medicare claims from calgb breast cancer trial participants companion to 9344, jnci. Calgb 30610 rtog 0538 piyunjie lin, md nct 00632853 coordinatorangie patterson a phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin or carboplatin and etoposide hcrn lun17302 pi maitri kalra, md nct 039455 coordinatorangie patterson. Leukemia group b trials calgb 30904 reported that total. A phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide. Management of all in adults national cancer institute. Registration to calgb 30610 must take place within 1421 days after the start of the nonprotocol therapy. Radiation dose and fractionation for limitedstage smallcell lung.
Ea11 a randomized phase iii postoperative trial of platinum based chemotherapy vs. Adjuvant lung schema protocol informationlink to clinicaltrials. Lsclc treated on the experimental thoracic radiotherapy trt arms of calgb 30610 alliance rtog 0538. Rtog 0539 radiation therapy oncology group rtog 0539 phase ii trial of observation for lowrisk meningiomas and of radiotherapy for intermediate and highrisk meningiomas study chairs 6910. Failing to do all of the above will make the patient not. Phase iii comparison of thoracic radiotherapy regimens in. Radiation therapy regimens in treating patients with. A pediatric regimen for older adolescents and young adults. Indiana university health ball memorial cancer center. Multimodality therapy for limitedstagesmallcelllungcancer. This is a randomized phase ii trial for patients with localized, surgically resectable esophageal cancer designed to evaluate the early assessment of response to chemotherapy by metabolic. Phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide protocol informationlink to clinicaltrials.
Calgb 30610, a phase iii randomized controlled trial, was designed to compare three accepted regimens including 45 gy in 30 twicedaily fractions over 3 weeks, 70 gy in 35 daily fractions over seven weeks, and 61. Alternatively, you can also download the pdf file directly to your computer, from where it can be opened using a pdf reader. Calgb 100104 2 111511 calgb central office 230 west monroe street, suite 2050 chicago, il 606064703 tel. Drug dose modifications and schedule and initiation of supportive care interventions are often necessary because of expected toxicities and. Combination chemotherapy in treating patients with stage. Measuring diseasefree survival and cancer relapse using.
Prophylactic cranial irradiation overview collaborative group. Briefly, patients with histologically or cytologically confirmed stage iiiaiiib ajcc 2000 unresectable nsclc, eastern cooperative oncology group ecog performance status ps of 01, and normal organ and marrow function were eligible. The pdf file you selected should load here if your web browser has a pdf reader plugin installed for example, a recent version of adobe acrobat reader. A randomized phase ii trial of myeloablative versus nonmyeloablative consolidation chemotherapy for newly diagnosed primary cns bcell lymphoma arm 1 and arm 2 receive the same induction therapy cycles 15. Calgb 30610rtog 0538 started as a 3 arm study designed to discontinue one of 2 ex. Patients not able to be treated within 3 days of day 22 should not be registered to calgb 30610. Calgb 30610 phase iii comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide. Calgb 80405 pdf asco, itt, kraswt primary os results. Rtog 0538calgb 30610 protocol student doctor network. To download the pdf, click the download link below. Combination chemotherapy in treating patients with stage iii colon cancer the safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Calgb 30610 thoracic radiotherapy for limited stage small cell. Ea6141, randomized phase iiiii study of nivolumab plus ipilimumab plus sargramostim.
Additional information from nci is available on the ctep coronavirus guidance page. Interruptions of oncedaily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer. Calgb 30105 eligibility criteria have been published previously. Announcements from nci and the lpos will be posted as they are received. Failing to do all of the above will make the patient not eligible for calgb. Is it time to convert the frequency of radiotherapy in. Bhs guidelines for the treatment of burkitts lymphoma. Failing to do all of the above will make the patient not eligible for calgb 30610. Listing a study does not mean it has been evaluated by the u. Looks like it has been removed from the rtog website. Patients may be registered to calgb 30610 following one cycle of chemotherapy. Three different radiation therapy regimens in treating. Calgb 10603ctsu c10603 2 040108 calgb central office 230 west monroe street, suite 2050 chicago, il 606064703 tel.
Checklist for submission of radiation oncology quality assurance materials. Use the covid19 button located at the top of the ctsu members website to access the covid19 information page. Treated with combination chemotherapy calgb lung nct00698815 pemetrexed andor sunitinib as second. Calgb 30610 phase ill comparison of thoracic radiotherapy regimens with cisplatin and etoposide in limited small cell lung cancer patient eligibility histologically or cytologically documented small cell lung cancer of limited stage see section 4. Patients with direct invasion of the vertebral bodies or. Patients must receive the second cycle of therapy following registration, on day 2224, so that the patient adheres to a 3week treatment cycle. Acute leukemia group b, algb is a cancer research cooperative group in the united states calgb research is focused on seven major disease areas.
1075 518 437 334 7 1228 178 1009 801 1333 858 375 1496 998 786 173 803 405 788 1029 1502 436 1259 1052 474 182 413 743 1206 1205 1343 527 928 486 112 1309 919 1370